Filing Details

Accession Number:
0000899243-17-008553
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-24 18:07:19
Reporting Period:
2017-03-24
Filing Date:
2017-03-24
Accepted Time:
2017-03-24 18:07:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662930 Niraj Vasisht C/O Biodelivery Sciences Intl, Inc.,
4131 Parklake Ave., Suite 225
Raleigh NC 27612
Svp & Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-22 1,474 $0.00 272,943 No 4 A Direct
Common Stock Disposition 2017-03-23 530 $1.90 272,413 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2017-03-22 1,474 $0.00 1,474 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2017-03-21 2017-03-22 No 4 A Direct
Footnotes
  1. The shares of common stock reported on this Form 4 were acquired by the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's Long Term Incentive Plan.
  2. The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.